Subscribe to RSS - Fisher & Paykel Healthcare

Fisher & Paykel Healthcare

F&P’s nasal high flow therapy in spotlight

 - 
07/02/2020

IRVINE, Calif. – Fisher & Paykel Healthcare’s Optiflow nasal high flow therapy has gained traction as a preferred treatment for COVID-19, as hospitals move away from an “early intubation and mechanical ventilation” mentality, company officials say.

F&P’s homecare group sees 9% increase in revenues

 - 
06/30/2020

IRVINE, Calif. – Fisher & Paykel Healthcare reported operating revenue of $1.26 billion for its fiscal year ended March 31, 2020, an 18% increase compared to 2019 or a 14% increase in constant currency.

F&P upgrades guidance

 - 
08/29/2019

IRVINE, Calif. – Fisher & Paykel Healthcare has upgraded its guidance for the financial year ending March 31, 2020, to full operating revenue of about $1.17 billion and net profit after tax of about $245 million to $255 million.

ResMed, F&P put patent disputes behind them

 - 
02/20/2019

SAN DIEGO and AUCKLAND, N.Z. – ResMed and Fisher & Paykel Healthcare have agreed to settle all outstanding patent infringement disputes between the two companies.

ResMed wins in German court

 - 
10/23/2018

SAN DIEGO – A trial court ruling from the Munich District Court says the headgear used on two CPAP masks from Fisher & Paykel Healthcare—the Simplus full-face and Eson nasal—infringes a ResMed patent in Germany.

New leadership: Fisher & Paykel, BioScrip

 - 
10/23/2018

Fisher & Paykel Healthcare has appointed Lyndal York CFO. She will join the company in March 2019 and will report to CEO Lewis Gradon.

Research backs use of myAirvo device for COPD, F&P says

 - 
04/20/2018

AUCKLAND, New Zealand – Fisher & Paykel Healthcare says new research that has been published in the International Journal of COPD shows significant benefits of nasal high flow therapy for COPD patients using its myAirvo device.

F&P files lawsuit in Australia

 - 
12/12/2017

AUCKLAND, New Zealand – Fisher & Paykel Healthcare filed patent infringement proceedings against ResMed in the Federal Court of Australia on Dec.

In brief: Inconsistencies in bid program, Trump’s new HHS nominee

 - 
11/16/2017

BALTIMORE – CMS did not always follow its own procedures and federal requirements for awarding competitive bidding contracts consistently, according to a new report from the Office of Inspector General.

German court sides with ResMed

 - 
10/13/2017

SAN DIEGO – ResMed says that a Munich District Court has decided that its AirSense 10 and AirCurve 10 CPAP devices and its Lumis ventilators, along with their humidifiers, do not infringe a Fisher & Paykel short-term patent, StreetInsider reports.

Pages